|
|||||||
| |||||||
| |||||||
1 | AN ACT concerning health.
| ||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||
3 | represented in the General Assembly:
| ||||||
4 | Section 5. The Department of Public Health Powers and | ||||||
5 | Duties Law of the
Civil Administrative Code of Illinois is | ||||||
6 | amended by adding Section 2310-353 as follows: | ||||||
7 | (20 ILCS 2310/2310-353 new) | ||||||
8 | Sec. 2310-353. Cervical Cancer Elimination Task Force. | ||||||
9 | (a) A standing Task Force on Cervical Cancer Elimination | ||||||
10 | ("Task Force") is established within the Illinois Department of | ||||||
11 | Public Health. | ||||||
12 | (b) The Task Force shall have 12 members appointed by the | ||||||
13 | Director of Public Health as follows: | ||||||
14 | (1) A representative of an organization relating to | ||||||
15 | women and cancer. | ||||||
16 | (2) A representative of an organization providing | ||||||
17 | health care to women. | ||||||
18 | (3) A health educator. | ||||||
19 | (4) A representative of a national organization | ||||||
20 | relating to cancer treatment who is an oncologist. | ||||||
21 | (5) A representative of the health insurance industry. | ||||||
22 | (6) A representative of a national organization of | ||||||
23 | obstetricians and gynecologists. | ||||||
24 | (7) A representative of a national organization of | ||||||
25 | family physicians. | ||||||
26 | (8) The State Epidemiologist. | ||||||
27 | (9) A member at-large with an interest in women's | ||||||
28 | health. | ||||||
29 | (10) A social marketing expert on health issues. | ||||||
30 | (11) A licensed registered nurse. | ||||||
31 | (12) A member of the Illinois Breast and Cervical | ||||||
32 | Cancer Medical Advisory Committee. |
| |||||||
| |||||||
1 | The directors of Public Health and Public Aid, and the | ||||||
2 | Secretary of Human Services, or their designees, and the Chair | ||||||
3 | and Vice-Chair of the Conference of Women Legislators in | ||||||
4 | Illinois, or their designees, shall be ex officio members of | ||||||
5 | the Task Force. The Director of Public Health shall also | ||||||
6 | consult with the Speaker of the House of Representatives, the | ||||||
7 | Minority Leader of the House of Representatives, the President | ||||||
8 | of the Senate, and the Minority Leader of the Senate in the | ||||||
9 | designation of members of the Illinois General Assembly as | ||||||
10 | ex-officio members. | ||||||
11 | Appointments to the Task Force should reflect the | ||||||
12 | composition of the Illinois population with regard to ethnic, | ||||||
13 | racial, age, and religious composition. | ||||||
14 | (c) The Director of Public Health shall appoint a Chair | ||||||
15 | from among the members of the Task Force. The Task Force shall | ||||||
16 | elect a Vice-Chair from its members. Initial appointments to | ||||||
17 | the Task Force shall be made not later than 30 days after the | ||||||
18 | effective date of this amendatory Act of the 93rd General | ||||||
19 | Assembly. A majority of the Task Force shall constitute a | ||||||
20 | quorum for the transaction of its business. The Task Force | ||||||
21 | shall meet at least quarterly. The Task Force Chair may | ||||||
22 | establish sub-committees for the purpose of making special | ||||||
23 | studies; such sub-committees may include non-Task-Force | ||||||
24 | members as resource persons. | ||||||
25 | (d) Members of the Task Force shall be reimbursed for their | ||||||
26 | necessary expenses incurred in performing their duties. The | ||||||
27 | Department of Public Health shall provide staff and technical | ||||||
28 | assistance to the Task Force to the extent possible within | ||||||
29 | annual appropriations for its ordinary and contingent | ||||||
30 | expenses. | ||||||
31 | (e) The Task Force shall have the following duties: | ||||||
32 | (1) To obtain from the Department of Public Health, if | ||||||
33 | available, data and analyses regarding the prevalence and | ||||||
34 | burden of cervical cancer. The Task Force may conduct or | ||||||
35 | arrange for independent studies and analyses. | ||||||
36 | (2) To coordinate the efforts of the Task Force with |
| |||||||
| |||||||
1 | existing State committees and programs providing cervical | ||||||
2 | cancer screening, education, and case management. | ||||||
3 | (3) To raise public awareness on the causes and nature | ||||||
4 | of cervical cancer, personal risk factors, the value of | ||||||
5 | prevention, early detection, options for testing, | ||||||
6 | treatment costs, new technology, medical care | ||||||
7 | reimbursement, and physician education. | ||||||
8 | (4) To identify priority strategies, new technologies, | ||||||
9 | and newly introduced vaccines that are effective in | ||||||
10 | preventing and controlling the risk of cervical cancer. | ||||||
11 | (5) To identify and examine the limitations of existing | ||||||
12 | laws, regulations, programs, and services with regard to | ||||||
13 | coverage and awareness issues for cervical cancer, | ||||||
14 | including requiring insurance or other coverage for PAP | ||||||
15 | smears and mammograms in accordance with the most recently | ||||||
16 | published American Cancer Society guidelines. | ||||||
17 | (6) To develop a statewide comprehensive Cervical | ||||||
18 | Cancer Prevention Plan and strategies for implementing the | ||||||
19 | Plan and for promoting the Plan to the general public, | ||||||
20 | State and local elected officials, and various public and | ||||||
21 | private organizations, associations, businesses, | ||||||
22 | industries, and agencies. | ||||||
23 | (7) To receive and to consider reports and testimony | ||||||
24 | from individuals, local health departments, | ||||||
25 | community-based organizations, voluntary health | ||||||
26 | organizations, and other public and private organizations | ||||||
27 | statewide to learn more about their contributions to | ||||||
28 | cervical cancer diagnosis, prevention, and treatment and | ||||||
29 | more about their ideas for improving cervical cancer | ||||||
30 | prevention, diagnosis, and treatment in Illinois. | ||||||
31 | (f) The Task Force shall submit a report to the Governor | ||||||
32 | and the General Assembly by April 1, 2005 and by April 1 of | ||||||
33 | each year thereafter. The report shall include (i) information | ||||||
34 | regarding the progress being made in fulfilling the duties of | ||||||
35 | the Task Force and in developing the Cervical Cancer Prevention | ||||||
36 | Plan and (ii) recommended strategies or actions to reduce the |
| |||||||
| |||||||
1 | occurrence of cervical cancer and the burdens from cervical | ||||||
2 | cancer suffered by citizens of this State. | ||||||
3 | (g) The Task Force shall expire on April 1, 2009, or upon | ||||||
4 | submission of the Task Force's final report to the Governor and | ||||||
5 | the General Assembly, whichever occurs earlier.
| ||||||
6 | Section 99. Effective date. This Act takes effect upon | ||||||
7 | becoming law.
|